-+ 0.00%
-+ 0.00%
-+ 0.00%

AMNEAL ANNOUNCES FULL STUDY POPULATION INTERIM PHASE 4 ELEVATE-PD RESULTS, REINFORCING PREVIOUSLY REPORTED BENEFITS OF CREXONT® IN PARKINSON'S DISEASE

Reuters·06/05/2026 12:00:01

Please log in to view news